Coronary and Structural Interventions Ulm - Transcatheter Mitral Valve Repair (CSI-Ulm-TMVR)
Not Applicable
Completed
- Conditions
- Mitral Valve Regurgitation
- Registration Number
- NCT03104660
- Lead Sponsor
- University of Ulm
- Brief Summary
To evaluate the long-term results after transcatheter mitral valve repair
- Detailed Description
Patients with transcatheter mitral valve repair are followed for 10 years to demonstrate efficacy and safety.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 355
Inclusion Criteria
- mitral valve regurgitation
- transcatheter mitral valve repair
Exclusion Criteria
- no written informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Major adverse cerebral and cardiac events 10 years Major adverse cerebral and cardiac events
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the long-term outcomes of transcatheter mitral valve repair in patients with degenerative mitral valve regurgitation?
How does transcatheter mitral valve repair compare to surgical mitral valve repair in terms of efficacy and safety for functional mitral regurgitation?
What biomarkers are associated with improved survival following transcatheter mitral valve repair in severe MR patients?
What are the potential adverse events and management strategies for transcatheter mitral valve repair using MitraClip technology?
Are there any novel molecular targets or combination therapies being explored alongside transcatheter mitral interventions for heart failure patients?
Trial Locations
- Locations (1)
University Hospital Ulm
🇩🇪Ulm, Germany
University Hospital Ulm🇩🇪Ulm, Germany